Thoracic transplantationOutcomeLessons Learned With Noninvasive Cardiac Monitoring for Acute Rejection
Outcome
Section snippets
Methods
Computerized Heart Allograft Rejection Monitoring (CHARM) evaluates parts of the ventricular evoked response (VER; Fig 1).
OHT was performed using the standard technique on recipients who received induction therapy with antithymocyte globulin followed by cyclosporine, azathioprine, or mycophenolate mofetil and aprednisolone.
During OHT 2 unipolar, fractally coated, screw-in leads (ELC 54-UP, Biotronik, Berlin, Germany) were implanted epimyocardially: one into the left ventricle lateral wall and a
References (12)
- et al.
Introducing a new clinical method for noninvasive rejection monitoring after heart transplantation to clinical practice: analysis of paced intramyocardial electrograms
Transplant Proc
(1998) - et al.
Noninvasive cardiac allograft monitoring
Transplant Proc
(2001) - et al.
Noninvasive heart monitoring after heart transplantation with CHARM (computerized heart allograft recipient monitoring): clinical experience
Transplant Proc
(2000) International Figures on organ donation and Transplantation 2003
Eurotransplant Newsletter
(2004)- et al.
Usefulness of the QTc interval in predicting acute allograft rejection
Thorac Cardiovasc Surg
(1998) - et al.
Tricuspidal valve insufficiency as complication of endomyocardial biopsy
Transplant Int
(1992)
There are more references available in the full text version of this article.
Cited by (2)
Myeloperoxidase and carbonyl proteins: Promising markers for non-invasive monitoring of graft rejection after heart transplantation
2010, Journal of Heart and Lung TransplantationBiomarkers of acute rejection following cardiac transplantation
2014, Biomarkers in Medicine
Copyright © 2007 Elsevier Inc. All rights reserved.